OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
This positions its platform as a rapidly evolving engine for next-generation genetic medicine
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
Baxfendy works in a fundamentally different way from current therapies
Access to genomic testing, not therapy cost, is the biggest challenge
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Subscribe To Our Newsletter & Stay Updated